United Therapeutics Corporation Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
AKRO
Akero Therapeutics, Inc. |
$24.02 | $1.59 B | -7.1 | 60 | $0 |
ALNY
Alnylam Pharmaceuticals, Inc. |
$249.16 | $19.33 B | -57.65 | 2100 | $1.83 B |
APLS
Apellis Pharmaceuticals, Inc. |
$29.68 | $4.90 B | -11.77 | 702 | $396.59 M |
ASND
Ascendis Pharma A/S |
$131.88 | $7.77 B | -14.19 | 879 | $266.72 M |
BGNE
BeiGene, Ltd. |
$184.71 | $17.07 B | -20.76 | 10600 | $2.46 B |
BPMC
Blueprint Medicines Corporation |
$103.88 | $6.47 B | -21.48 | 638 | $249.38 M |
DAWN
Day One Biopharmaceuticals, Inc. |
$12.39 | $1.12 B | -5.11 | 174 | $0 |
INCY
Incyte Corporation |
$72.50 | $13.30 B | 17.93 | 2524 | $3.70 B |
KNSA
Kiniksa Pharmaceuticals, Ltd. |
$18.40 | $1.35 B | 146.62 | 297 | $270.26 M |
LEGN
Legend Biotech Corporation |
$31.43 | $8.31 B | -17.66 | 2400 | $285.14 M |
LRMR
Larimar Therapeutics, Inc. |
$3.24 | $611.84 M | -9.99 | 42 | $0 |
MNKD
MannKind Corporation |
$6.01 | $1.27 B | 116.75 | 411 | $198.96 M |
NUVL
Nuvalent, Inc. |
$76.08 | $5.11 B | -32.72 | 127 | $0 |
PCVX
Vaxcyte, Inc. |
$87.82 | $7.72 B | -16.54 | 254 | $0 |
RARE
Ultragenyx Pharmaceutical Inc. |
$40.85 | $3.44 B | -5.21 | 1276 | $434.25 M |
REPL
Replimune Group, Inc. |
$10.42 | $485.18 M | -2.44 | 331 | $0 |
VTYX
Ventyx Biosciences, Inc. |
$1.89 | $229.83 M | -1.01 | 75 | $0 |